{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:13:12Z","timestamp":1792699992044,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1067\/mjd.2002.120473","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T22:14:26Z","timestamp":1030227266000},"page":"58-62","source":"Crossref","is-referenced-by-count":74,"title":["Increased interleukin 10, tumor necrosis factor \u03b1, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis"],"prefix":"10.1067","volume":"47","author":[{"given":"Osvaldo","family":"Correia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Leal","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Campilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Fleming-Torrinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2002.120473_bib1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib2","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.120473_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000247299","article-title":"Evolving pattern of drug-induced toxic epidermal necrolysis","volume":"186","author":"Correia","year":"1993","journal-title":"Dermatology"},{"key":"10.1067\/mjd.2002.120473_bib4","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0190-9622(90)70307-4","article-title":"Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases","volume":"23","author":"Villada","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archderm.1991.01680050095011","article-title":"T-cell subsets in drug-induced toxic epidermal necrolysis: possible pathogenic mechanism induced by CD8-positive T cells","volume":"127","author":"Miyauchi","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.1993.01680250078010","article-title":"Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement","volume":"129","author":"Correia","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","article-title":"Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors","volume":"119","author":"Cleach","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1067\/mjd.2002.120473_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1523-1747.2000.00037.x","article-title":"Death receptors in cutaneous biology and disease","volume":"115","author":"Wehrli","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib9","first-page":"1656","article-title":"Fas-mediated cell death in toxic epidermal necrolysis and graft-versus-host disease: potential for therapeutic inhibition","volume":"130","author":"French","year":"2000","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1067\/mjd.2002.120473_bib10","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.4049\/jimmunol.162.12.7140","article-title":"Crosstalk between keratinocytes and T lymphocytes via Fas\/Fas ligand interaction: modulation by cytokines","volume":"162","author":"Arnold","year":"1999","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2002.120473_bib11","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1084\/jem.183.6.2645","article-title":"The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice","volume":"183","author":"Baker","year":"1996","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120473_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.183.2.657","article-title":"Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease","volume":"183","author":"Braun","year":"1996","journal-title":"J Exp Med"},{"issue":"Suppl","key":"10.1067\/mjd.2002.120473_bib13","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1067\/mai.2000.106060","article-title":"Serum markers of graft-versus-host disease after bone marrow transplantation","volume":"106","author":"Kayaba","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mjd.2002.120473_bib14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V75.4.1011.1011","article-title":"Increased serum levels of tumor necrosis factor \u03b1 precede major complications of bone marrow transplantation","volume":"75","author":"Holler","year":"1990","journal-title":"Blood"},{"key":"10.1067\/mjd.2002.120473_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.bmt.1700936","article-title":"Inverse correlation of interleukin-6 with soluble interleukin-6 receptor after transplantation of bone marrow or peripheral blood stem cells","volume":"20","author":"Steffen","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1067\/mjd.2002.120473_bib16","first-page":"459","article-title":"Soluble fractions of tumor necrosis factor-alpha, interleukin-6 and of their receptors in toxic epidermal necrolysis: a comparison with second-degree burns","volume":"1","author":"Paquet","year":"1998","journal-title":"Int J Mol Med"},{"key":"10.1067\/mjd.2002.120473_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bmt.1702010","article-title":"Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation","volume":"24","author":"Takatsuka","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1067\/mjd.2002.120473_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000236329","article-title":"Functional characterization of human IL-10","volume":"99","author":"Spits","year":"1992","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1067\/mjd.2002.120473_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.iy.11.040193.001121","article-title":"Interleukin-10","volume":"11","author":"Moore","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"10.1067\/mjd.2002.120473_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib21","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(85)90918-3","article-title":"Adverse drug reaction monitoring: doing it in the French way","volume":"2","author":"Moore","year":"1985","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.120473_bib22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/archderm.134.5.602","article-title":"Cutaneous graft-versus-host disease","volume":"134","author":"Aractingi","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0190-9622(98)70495-5","article-title":"Graft-versus-host reactions in dermatology","volume":"38","author":"Johnson","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Paul","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0190-9622(96)90320-5","article-title":"Apoptosis is the mode of keratinocyte death in cutaneous graft versus host disease","volume":"35","author":"Langley","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1469-7793.2000.00653.x","article-title":"Circulating interleukin-6 mediates the febrile response to localized inflammation in rats","volume":"526","author":"Cartmell","year":"2000","journal-title":"J Physiol"},{"key":"10.1067\/mjd.2002.120473_bib27","first-page":"R81","article-title":"An antipyretic role for interleukin-10 in LPS fever in mice","volume":"276","author":"Leon","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1067\/mjd.2002.120473_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.149.1.92","article-title":"Identification and induction of keratinocyte-derived IL-10","volume":"149","author":"Enk","year":"1992","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2002.120473_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/000155599750010689","article-title":"Blister fluid cytokines in cutaneous inflammatory bullous disorders","volume":"79","author":"Rhodes","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1067\/mjd.2002.120473_bib30","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.120473_bib31","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood.V86.4.1243.bloodjournal8641243","article-title":"Interleukin-6 family of cytokines and gp130","volume":"86","author":"Kishimoto","year":"1995","journal-title":"Blood"},{"key":"10.1067\/mjd.2002.120473_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0190-9622(91)70102-8","article-title":"Tumor necrosis factor","volume":"24","author":"Wakefield","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib33","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/1523-1747.ep12696816","article-title":"Lymphotoxin, tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes","volume":"92","author":"Symington","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2133.1998.02341.x","article-title":"Bullous pemphigoid blisters of the same duration have similar cytokine concentrations which decrease in older blisters","volume":"139","author":"Giacalone","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib35","first-page":"429","article-title":"Tumor necrosis factor in blister fluids of bullous pemphigoid","volume":"2","author":"Zillikens","year":"1992","journal-title":"Eur J Dermatol"},{"key":"10.1067\/mjd.2002.120473_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF02507102","article-title":"Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid","volume":"288","author":"Schmidt","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1067\/mjd.2002.120473_bib37","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1006\/cyto.1999.0642","article-title":"Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid","volume":"12","author":"Bhol","year":"2000","journal-title":"Cytokine"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220200018X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220200018X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T20:58:49Z","timestamp":1682283529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096220200018X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S019096220200018X"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2002.120473","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}